There are 500 million obese individuals across the world, a number that global health organizations are desperately trying to lower. But where public health workers see crisis, Bank of America sees an investment opportunity. On Monday, BofA analysts released a list of 50 stocks for “investors wishing to play the global fight against obesity theme.”
The 50 investment opportunities fall into four broad categories: pharmaceuticals and health care, food, commercial weight loss and sportswear. What the investments all have in common is a potential to gain from efforts to cut down global obesity rates.
The biggest winners in the health-care group, the analysts note, could be the medical device companies. They “are playing an increasingly important role in dealing with the impact of obesity-related co-morbidities, including heart disease and failure, type 2 diabetes, kidney failure, respiratory complications (e.g. obstructive sleep apnea), osteoarthritis and incontinence.”